Oncology Product Manufacturing in a Nondedicated Facility

Article

Sponsored Content

- Advantages of manufacturing immuno-oncology therapies in multiproduct facilities - Preventing cross-contamination and proper cleaning validation

Newsletter

Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.

Subscribe Now!
Related Content
Site Logo

Executive Summary: Keys to Supplying Decentralized Trials: The Value of Direct-to-Patient Solutions and the Pharmacy-Led Model

Catalent
July 18th 2025
Article
Site Logo

Innovations in Pregastric Absorption Drug Delivery & Orally Disintegrating Tablets

Catalent
July 16th 2025
Article
Site Logo

Rethinking Inhalation Drug Development

Experic
July 15th 2025
Article

What it takes to bring complex inhaled therapies to market—faster and smarter.

Site Logo

CDMO Solutions – Reducing Risk and Accelerating Time to Market

Experic
July 15th 2025
Article

Discover how our precision processes and dedicated personal support can expedite even the most complex drug programs.

Site Logo

Unparalleled Expertise and Transparency Drive a Unique Development, Manufacturing, and Clinical Supply Experience

Experic
July 15th 2025
Article

Site Logo

Streamlined Product Development Leveraging Pharmaceutical Classification Models

Serán
July 11th 2025
Article